Trader Lebenthal, up 30% this year, makes Pfizer a top holding

Traders gather at the post of Pfizer on the floor of the New York Stock Exchange in New York.
Brendan McDermid | Reuters

Trader Jim Lebenthal, whose "Halftime Report" model portfolio is up 30 percent this year, added Pfizer as one of this top holdings for the competition.

Here's why: